{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:15:40Z","timestamp":1760044540316},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T00:00:00Z","timestamp":1187136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00404-007-0434-1","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:55:17Z","timestamp":1187092517000},"page":"135-138","source":"Crossref","is-referenced-by-count":19,"title":["COX-2 and Her-2\/neu are overexpressed in Paget\u2019s disease of the vulva and the breast: results of a preliminary study"],"prefix":"10.1007","volume":"277","author":[{"given":"Lars-Christian","family":"Horn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Purz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Krumpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Bilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"key":"434_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjc.6601534","volume":"90","author":"GP Boland","year":"2004","unstructured":"Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ (2004) COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 90:423\u2013429","journal-title":"Br J Cancer"},{"key":"434_CR2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2004.07.043","volume":"95","author":"O Brummer","year":"2004","unstructured":"Brummer O, Stegner HE, Bohmer G, Kuhnle H, Petry KU (2004) HER-2\/neu expression in Paget disease of the vulva and the female breast. Gynecol Oncol 95:336\u2013340","journal-title":"Gynecol Oncol"},{"key":"434_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00004347-199910000-00010","volume":"18","author":"D Crawford","year":"1999","unstructured":"Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Gilks CB (1999) Prognostic factors in Paget\u2019s disease of the vulva: a study of 21 cases. Int J Gynecol Pathol 18:351\u2013359","journal-title":"Int J Gynecol Pathol"},{"key":"434_CR4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/annonc\/mdf125","volume":"13","author":"G Davies","year":"2002","unstructured":"Davies G, Martin LA, Sacks N, Dowsett M (2002) Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol 13:669\u2013678","journal-title":"Ann Oncol"},{"key":"434_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00192631","volume":"426","author":"CR Potter De","year":"1995","unstructured":"De Potter CR, Schelfhout AM (1995) The neu-protein and breast cancer. Virchows Arch 426:107\u2013115","journal-title":"Virchows Arch"},{"key":"434_CR6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1381612043453126","volume":"10","author":"JF Evans","year":"2004","unstructured":"Evans JF, Kargman SL (2004) Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des 10:627\u2013634","journal-title":"Curr Pharm Des"},{"key":"434_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9378(99)70143-2","volume":"180","author":"J Fanning","year":"1999","unstructured":"Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C (1999) Paget\u2019s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget\u2019s disease, and recurrence after surgical excision. Am J Obstet Gynecol 180:24\u201327","journal-title":"Am J Obstet Gynecol"},{"key":"434_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2003.10.054","volume":"92","author":"G Ferrandina","year":"2004","unstructured":"Ferrandina G, Ranelletti FO, Salutari V, Gessi M, Legge F, Zannoni GF, Scambia G, Lauriola L (2004) Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions. Gynecol Oncol 92:537\u2013544","journal-title":"Gynecol Oncol"},{"key":"434_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/gyno.1995.1044","volume":"56","author":"DA Fishman","year":"1995","unstructured":"Fishman DA, Chambers SK, Schwartz PE, Kohorn EI, Chambers JT (1995) Extramammary Paget\u2019s disease of the vulva. Gynecol Oncol 56:266\u2013270","journal-title":"Gynecol Oncol"},{"key":"434_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2559.2003.01578.x","volume":"42","author":"H Fox","year":"2003","unstructured":"Fox H, Wells M (2003) Recent advances in the pathology of the vulva. Histopathology 42:209\u2013216","journal-title":"Histopathology"},{"key":"434_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jso.1090","volume":"77","author":"W Fu","year":"2001","unstructured":"Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC (2001) Molecular markers in Paget disease of the breast. J Surg Oncol 77:171\u2013178","journal-title":"J Surg Oncol"},{"key":"434_CR12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","volume":"16","author":"A Goldhirsch","year":"2005","unstructured":"Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ; Panel members (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569\u20131583","journal-title":"Ann Oncol"},{"key":"434_CR13","first-page":"1676","volume":"62","author":"E Half","year":"2002","unstructured":"Half E, Ming Tang X, Gwyn K, Sahin A, Wathen K, Sinicrope FA (2002) Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62:1676\u20131681","journal-title":"Cancer Res"},{"key":"434_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7:203\u2013205","journal-title":"Epidemiology"},{"key":"434_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1245\/ASO.2005.05.026","volume":"12","author":"K Kawase","year":"2005","unstructured":"Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK (2005) Paget\u2019s disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12:391\u2013397","journal-title":"Ann Surg Oncol"},{"key":"434_CR16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/modpathol.3800437","volume":"18","author":"B Liegl","year":"2005","unstructured":"Liegl B, Horn LC, Moinfar F (2005) Androgen receptors are frequently expressed in mammary and extramammary Paget\u2019s disease. Mod Pathol 18:1283\u20131288","journal-title":"Mod Pathol"},{"key":"434_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004347-199107000-00007","volume":"10","author":"DJ Olson","year":"1991","unstructured":"Olson DJ, Fujimura M, Swanson P, Okagaki T (1991) Immunohistochemical features of Paget\u2019s disease of the vulva with and without adenocarcinoma. Int J Gynecol Pathol 10:285\u2013295","journal-title":"Int J Gynecol Pathol"},{"key":"434_CR18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/modpathol.3800243","volume":"18","author":"O Reich","year":"2005","unstructured":"Reich O, Liegl B, Tamussino K, Regauer S (2005) p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget\u2019s disease. Mod Pathol 18:354\u2013357","journal-title":"Mod Pathol"},{"key":"434_CR19","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B","volume":"89","author":"RA Soslow","year":"2000","unstructured":"Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637\u20132645","journal-title":"Cancer"},{"key":"434_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mob.2002.125700","volume":"187","author":"S Tebes","year":"2002","unstructured":"Tebes S, Cardosi R, Hoffman M (2002) Paget\u2019s disease of the vulva. Am J Obstet Gynecol 187:281\u2013283","journal-title":"Am J Obstet Gynecol"},{"key":"434_CR21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.50.10.801","volume":"50","author":"PJ Diest van","year":"1997","unstructured":"van Diest PJ, van Dam P, Henzen-Logmans SC (1997) A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. Clin Pathol 50: 801\u2013804","journal-title":"Clin Pathol"},{"key":"434_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2559.2004.01898.x","volume":"45","author":"CJ Witton","year":"2004","unstructured":"Witton CJ, Hawe SJ, Cooke TG, Bartlett JM (2004) Cyclooxygenase-2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 45:47\u201354","journal-title":"Histopathology"},{"key":"434_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2133.2000.03242.x","volume":"142","author":"JD Zollo","year":"2000","unstructured":"Zollo JD, Zeitouni NC (2000) The Roswell Park Cancer Institute experience with extramammary Paget\u2019s disease. Br J Dermatol 142:59\u201365","journal-title":"Br J Dermatol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-007-0434-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-007-0434-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:44:51Z","timestamp":1559065491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-007-0434-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s00404-007-0434-1","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]}}}